The Company was recently awarded a full Good Manufacturing Practice (GMP) licence for its European Production and Manufacturing facility in Slovenia, following production of its first commercial batch of epilepsy medicine, CannEpil™. Receipt of this certification has advanced MGC Pharma towards the final stages for commercialisation which will follow the completion of final tests, CannEpilTM becoming available for supply in Australia under the Authorised Prescriber Scheme by the TGA, and its final validation.
- Forums
- ASX - By Stock
- RGT
- Christmas
Christmas, page-25
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.0¢ |
Change
0.065(39.4%) |
Mkt cap ! $11.13M |
Open | High | Low | Value | Volume |
18.0¢ | 23.0¢ | 17.5¢ | $97.37K | 451.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 18.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 6921 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.180 |
3 | 24185 | 0.170 |
2 | 18040 | 0.165 |
2 | 21250 | 0.160 |
3 | 51527 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 6921 | 5 |
0.250 | 42478 | 4 |
0.260 | 100 | 1 |
0.300 | 338 | 1 |
0.345 | 5950 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |